Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis

Inhibition of the sodium glucose co-transporter 2 (SGLT2) reduces cardiovascular morbidity, and mortality in patients with type 2 diabetes mellitus (T2DM) with atherosclerotic, cardiovascular disease. So far, a link between common genetic variations of the SGLT2 encoding gene SLC5A2 and glucose home...

Descripción completa

Detalles Bibliográficos
Autores principales: Drexel, Heinz, Leiherer, Andreas, Saely, Christoph H., Brandtner, Eva Maria, Geiger, Kathrin, Vonbank, Alexander, Fraunberger, Peter, Muendlein, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684948/
https://www.ncbi.nlm.nih.gov/pubmed/30988077
http://dx.doi.org/10.1042/BSR20190299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684948/
https://www.ncbi.nlm.nih.gov/pubmed/30988077
http://dx.doi.org/10.1042/BSR20190299

Ejemplares similares